Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Melatonin and Sleep Disturbances in Alzheimer's Disease

Prodhan AHMSU, Cavestro C, Kamal MA, Islam MA.

CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617.

Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols

Zhang M, Hu G, Shao N, Qin Y, Chen Q, Wang Y, Zhou P, Cai B.

Inflammopharmacology. 2021 Oct;29(5):1317-1329. doi: 10.1007/s10787-021-00861-4. Epub 2021 Aug 4.

Recent Progress Towards Vaccines and Antibody-based Therapies Against Alzheimer's Disease

Ji W, Gong B, Jin H, Chen X, Li P, Cheng W, Zhao Y, He B, Zhuang J, Gao J, Yin Y.

Mini Rev Med Chem. 2021;21(19):3062-3072. doi: 10.2174/1389557521666210805110920.

Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Bungau S.

Neurochem Res. 2021 Nov;46(11):2832-2851. doi: 10.1007/s11064-021-03415-w. Epub 2021 Aug 6.

Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review

Yu TW, Lane HY, Lin CH.

Int J Mol Sci. 2021 Jul 30;22(15):8208. doi: 10.3390/ijms22158208.

The Ultrastructure of Tissue Damage by Amyloid Fibrils

Koike H, Katsuno M.

Molecules. 2021 Jul 29;26(15):4611. doi: 10.3390/molecules26154611.

Cellular senescence at the crossroads of inflammation and Alzheimer's disease

Guerrero A, De Strooper B, Arancibia-Cárcamo IL.

Trends Neurosci. 2021 Sep;44(9):714-727. doi: 10.1016/j.tins.2021.06.007. Epub 2021 Aug 5.

A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease

Mukhopadhyay S, Banerjee D.

J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.

Untangling huge literature to disinter genetic underpinnings of Alzheimer's Disease: A systematic review and meta-analysis

G N S HS, Marise VLP, Satish KS, Yergolkar AV, Krishnamurthy M, Ganesan Rajalekshmi S, Radhika K, Burri RR.

Ageing Res Rev. 2021 Nov;71:101421. doi: 10.1016/j.arr.2021.101421. Epub 2021 Aug 8.

Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research

Bi FC, Yang XH, Cheng XY, Deng WB, Guo XL, Yang H, Wang Y, Li J, Yao Y.

Transl Neurodegener. 2021 Aug 9;10(1):27. doi: 10.1186/s40035-021-00252-3.

Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products

Rather MA, Khan A, Alshahrani S, Rashid H, Qadri M, Rashid S, Alsaffar RM, Kamal MA, Rehman MU.

Mediators Inflamm. 2021 Jul 31;2021:9982954. doi: 10.1155/2021/9982954. eCollection 2021.

Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential

Sharma VK, Singh TG, Singh S, Garg N, Dhiman S.

Neurochem Res. 2021 Dec;46(12):3103-3122. doi: 10.1007/s11064-021-03418-7. Epub 2021 Aug 12.

Formaldehyde-Crosslinked Nontoxic Aβ Monomers to Form Toxic Aβ Dimers and Aggregates: Pathogenicity and Therapeutic Perspectives

Zhao H, Huang X, Tong Z.

ChemMedChem. 2021 Nov 19;16(22):3376-3390. doi: 10.1002/cmdc.202100428. Epub 2021 Sep 8.

The Structure Biology of Tau and Clue for Aggregation Inhibitor Design

Wang D, Huang X, Yan L, Zhou L, Yan C, Wu J, Su Z, Huang Y.

Protein J. 2021 Oct;40(5):656-668. doi: 10.1007/s10930-021-10017-6. Epub 2021 Aug 17.

Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease

Apátiga-Pérez R, Soto-Rojas LO, Campa-Córdoba BB, Luna-Viramontes NI, Cuevas E, Villanueva-Fierro I, Ontiveros-Torres MA, Bravo-Muñoz M, Flores-Rodríguez P, Garcés-Ramirez L, de la Cruz F, Montiel-Sosa JF, Pacheco-Herrero M, Luna-Muñoz J.

Metab Brain Dis. 2022 Jan;37(1):39-50. doi: 10.1007/s11011-021-00814-4. Epub 2021 Aug 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias